ABSTRACT NUMBER: ESOC2026A438 EARLY DETECTION OF PEDIATRIC FAMILIAL HYPERCHOLESTEROLEMIA THROUGH REVERSE CASCADE SCREENING AND STROKE RISK SIGNALS: PRELIMINARY RESULTS FROM THE EPIRUS PROJECT

Abstract Background and aims Familial hypercholesterolemia (FH) is associated with lifelong exposure to elevated LDL-cholesterol and a markedly increased risk of atherosclerotic cardiovascular disease (ASCVD). The EPIRUS FH Reverse Cascade Project applies targeted family-based screening in Northwestern Greece, enabling pediatric identification and assessment of vascular risk, including cerebrovascular events. Methods Children aged 4 to 16 years were enrolled if they met at least one of the following: LDL-cholesterol >160 mg/dL or >130 mg/dL plus family history of hyperlipidemia and/or premature ASCVD or current lipid-lowering therapy. All participants (n=230) underwent standardized clinical evaluation, detailed lipid profiling and next generation sequencing. Stroke and coronary artery disease (CAD) history was recorded in children, parents, and grandparents. Results Children were classified as genotype positive FH (GP, n=123). Median age was 9.0 years and 119 children (51.7%) were female. Compared with genotype-negative (GN), GP children had significantly higher levels of total and LDL-cholesterol, triglycerides, and apolipoprotein B, and lower HDL-cholesterol and apolipoprotein AI. Premature CAD in first-degree relatives was more frequent in GP families (60% vs 37%). “Cryptogenic” ischemic stroke was recorded in 1 genotype-positive child. Stroke history was reported in 3 parents and 8 grandparents of GP children, compared with 0 parents and 2 grandparents in GN families. Conclusions Reverse cascade screening efficiently identifies pediatric FH and reveals a substantial burden of premature CAD within affected families. In contrast, stroke was uncommon and markedly less frequent than CAD, supporting the concept that cerebrovascular manifestations tend to occur later in life, even in FH. (ClinicalTrials.gov ID NCT05825612) Conflict of interest None

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.293
Primary Topic
Lipoproteins and Cardiovascular Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A438 EARLY DETECTION OF PEDIATRIC FAMILIAL HYPERCHOLESTEROLEMIA THROUGH REVERSE CASCADE SCREENING AND STROKE RISK SIGNALS: PRELIMINARY RESULTS FROM THE EPIRUS PROJECT

Anastasios Serbis, Matilda Florentin, Eleana Hatzidaki, Panagiotis Apostolou et al.
European Stroke Journal
Lipoproteins and Cardiovascular Health
article

ABSTRACT NUMBER: ESOC2026A438 EARLY DETECTION OF PEDIATRIC FAMILIAL HYPERCHOLESTEROLEMIA THROUGH REVERSE CASCADE SCREENING AND STROKE RISK SIGNALS: PRELIMINARY RESULTS FROM THE EPIRUS PROJECT

Anastasios Serbis, Matilda Florentin, Eleana Hatzidaki, Panagiotis Apostolou, Aikaterini Nikolaou, Antonios Vlahos, Haralampos Milionis, Charilaos Kostoulas, Ioannis Papasotiriou, Fotios Barkas
article en

Abstract

Abstract Background and aims Familial hypercholesterolemia (FH) is associated with lifelong exposure to elevated LDL-cholesterol and a markedly increased risk of atherosclerotic cardiovascular disease (ASCVD). The EPIRUS FH Reverse Cascade Project applies targeted family-based screening in Northwestern Greece, enabling pediatric identification and assessment of vascular risk, including cerebrovascular events. Methods Children aged 4 to 16 years were enrolled if they met at least one of the following: LDL-cholesterol >160 mg/dL or >130 mg/dL plus family history of hyperlipidemia and/or premature ASCVD or current lipid-lowering therapy. All participants (n=230) underwent standardized clinical evaluation, detailed lipid profiling and next generation sequencing. Stroke and coronary artery disease (CAD) history was recorded in children, parents, and grandparents. Results Children were classified as genotype positive FH (GP, n=123). Median age was 9.0 years and 119 children (51.7%) were female. Compared with genotype-negative (GN), GP children had significantly higher levels of total and LDL-cholesterol, triglycerides, and apolipoprotein B, and lower HDL-cholesterol and apolipoprotein AI. Premature CAD in first-degree relatives was more frequent in GP families (60% vs 37%). “Cryptogenic” ischemic stroke was recorded in 1 genotype-positive child. Stroke history was reported in 3 parents and 8 grandparents of GP children, compared with 0 parents and 2 grandparents in GN families. Conclusions Reverse cascade screening efficiently identifies pediatric FH and reveals a substantial burden of premature CAD within affected families. In contrast, stroke was uncommon and markedly less frequent than CAD, supporting the concept that cerebrovascular manifestations tend to occur later in life, even in FH. (ClinicalTrials.gov ID NCT05825612) Conflict of interest None

European Stroke JournalVol. 11(Supplement_1)
University of Ioannina (GR), International Centre for Genetic Engineering and Biotechnology (ZA), Cancer Genetics (United States) (US)
Good health and well-being
Openalex Percentile: Top 9%
Lipoproteins and Cardiovascular Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.